The predominant B1R immunoreactive species (∼45 kDa) appearing in human glioma cells had a lower molecular-mass than that identified in rat glioma tissues (∼65 kDa) (Figure 1B), possibly due to differences in post-translational processing of B1R (ex. This evidence concerns the gene BDKRB1 and central nervous system cancer.